Amneal Pharmaceuticals Inc Class A (AMRX) Key Ratios

$21.23

up-down-arrow $9.05 (74.28%)

As on 20-Nov-2026 12:36EST

Market cap

info icon

$7,449 Mln

Revenue (TTM)

info icon

$3,196 Mln

P/E Ratio

info icon

53.5

P/B Ratio

info icon

14

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 8.35 9.96 8.88 10.22 9.11
EBIT -49.33 28.44 50.49 26.62 21.50
Net Profit -190.70 -209.52 255.71 49.82 28.58
EPS -112.64 -404.43 3,081.78 92.37 37.71
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 10.419.6514.8412.607.29
Net Margin info ---2.684.62----
Return on equity info 42.8018.43---80.04261.24
Return on Capital info -1.50-1.65--2.80-4.45
Return on Assets info -1.22-1.352.722.01-3.35
Debt to Equity (x) info ----5.49-38.65-23.73
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
--
2.80
-4.45
-2.84
-4.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
--
-80.04
261.24
-52.79
-39.46
Peer Median
15.89
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

2.72

Higher than Peers by 0.03

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
2.72
2.01
-3.35
-2.31
-3.36
Peer Median
2.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

14.84

Higher than Peers by 1.98

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
14.84
12.60
7.29
11.34
9.04
Peer Median
12.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

4.62

Lower than Peers by 2.85

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
4.62
2.39
-4.18
-3.51
-5.86
Peer Median
7.47
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

8.88

Higher than Peers by 0.33

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
8.88
0.08
0.17
0.08
0.06
Peer Median
8.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

50.49

Higher than Peers by 42.35

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
50.49
86.80
-24.98
35.67
19.29
Peer Median
8.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

255.71

Higher than Peers by 249.10

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
255.71
161.65
-39.16
35.38
-1,323.51
Peer Median
6.61
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

3,081.78

Higher than Peers by 3,072.93

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
3,081.78
1.59
-0.09
0.60
-13.06
Peer Median
8.85
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

569.48

Higher than Peers by 564.08

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
569.48
--
--
--
--
Peer Median
5.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

5.49

Higher than Peers by 5.05

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
5.49
-38.65
-23.73
139.05
9.53
Peer Median
0.44
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.42

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
0.42
-0.30
-3.11
11.51
0.35
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.87

Higher than Peers by 0.01

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
1.87
2.17
1.41
1.63
1.88
Peer Median
1.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.24

Lower than Peers by 0.10

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
1.24
1.48
0.86
0.94
1.17
Peer Median
1.34
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

1.99

Lower than Peers by 4.16

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
1.99
1.58
0.79
1.29
1.26
Peer Median
6.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

31.88

Higher than Peers by 10.59

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
31.88
31.13
27.76
26.97
33.53
Peer Median
21.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.59

Higher than Peers by 0.18

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
0.59
0.84
0.80
0.66
0.57
Peer Median
0.41
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
--
103.79
92.91
105.86
118.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
--
118.22
122.93
132.77
131.12
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
--
49.91
41.54
37.06
38.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
--
172.10
174.30
201.57
211.41
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

53.45

Lower than Peers by 1.39

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
53.45
56.80
-20.99
-17.61
-2.32
Peer Median
54.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

14.02

Higher than Peers by 6.74

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
14.02
-57.81
-22.46
74.79
1.01
Peer Median
7.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

16.56

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
16.56
10.79
11.22
8.26
7.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

7,449

Higher than Peers by 5,924

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Amneal Pharmaceuticals Inc Class A (AMRX)
7,449
--
--
--
--
Peer Median
1,525
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...